A Study of HBS-201 (Pitolisant Delayed-release)

Completed · Phase 1

Conditions studied: Narcolepsy

In brief

The purpose of this study is to assess the tolerability of HBS-201 when starting at a therapeutic dose in adult participants with narcolepsy.

Key facts

Study ID
NCT07051252
Run by
Harmony Biosciences Management, Inc.
People needed
46
Starts
2025-05-21
Expected to finish
2025-10-13
Last updated by the study team
2025-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.